r5gms09p | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Mackey%2C_Katherine%3B_Kansagara%2C_Devan%3B_Vela%2C_Kathryn>
?:doi	<https://research.tib.eu/covid-19/entity/10.7326/l20-0969>
?:doi	10.7326/l20-0969
?:journal	Ann_Intern_Med
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/376f4c312c19bac240bc3bc7a7f83230841970d0.json
?:pmc_json_files	document_parses/pmc_json/PMC7397547.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7397547>
?:pmid	<https://research.tib.eu/covid-19/entity/32701362.0>
?:pmid	32701362.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/376f4c312c19bac240bc3bc7a7f83230841970d0>
?:source	Medline; PMC
?:title	Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-07-23

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/r5gms09p>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/r5gms09p>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all